These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 22154895)

  • 1. [Lupus, Graves' disease, and vasculitis: a case report].
    Pinto Valdivia M
    Endocrinol Nutr; 2012 Mar; 59(3):222-4. PubMed ID: 22154895
    [No Abstract]   [Full Text] [Related]  

  • 2. Class IV lupus nephritis associated with Graves' disease.
    Fu LS; Yang LY; Chen WP; Chao T; Ooi SK; Lin CY
    Child Nephrol Urol; 1992; 12(1):51-4. PubMed ID: 1606584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case from practice (70). Patient: M. W., born 3 October 1945, saleswoman].
    Eichenberger M
    Schweiz Rundsch Med Prax; 1986 Dec; 75(52):1601-2. PubMed ID: 3809843
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of p-ANCA positive necrotizing vasculitis associated with Graves' disease].
    Aoki A; Suzuki H; Ohata T; Ohno S; Nagaoka S; Chiba J; Kanamaru T; Usuda Y
    Ryumachi; 1995 Aug; 35(4):683-7. PubMed ID: 7482066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions & answers. My doctor told me I might develop Cushing's syndrome because of the prednisone I take for kidney disease caused by lupus. What symptoms should I expect?
    Utiger RD
    Health News; 2003 Nov; 9(11):16. PubMed ID: 14619826
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report: dental considerations for managing a patient undergoing I-131 treatment for Graves' disease.
    Herren C; Lindroth J
    Gen Dent; 2003; 51(3):260-2. PubMed ID: 15055712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease.
    Metso S; Jaatinen P; Salmi J
    N Engl J Med; 2008 Sep; 359(13):1408-9; author reply 1409. PubMed ID: 18822460
    [No Abstract]   [Full Text] [Related]  

  • 12. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle weakness in a girl with autoimmune hepatitis and Graves' disease.
    Sarkhy A; Persad R; Tarnopolsky M
    Eur J Pediatr; 2009 Feb; 168(2):241-3. PubMed ID: 18604559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
    Lau D; Summers S; Amos L; Simpson I; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 18. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
    Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.